1 Long-term high blood pressure may damage the blood vessel health of the brain Recently, scientists from the University of Michigan School of Medicine and other institutions have discovered that […]
1 Lipoic acid supplements promote weight loss Recently, a study by Oregon State University and Oregon Health and Science University showed that the use of specific supplements-“lipoic acid” for overweight […]
With the development of the global epidemic, remdesivir has received continuous attention from the industry and the public. Earlier, preliminary results of a global clinical trial called ACTT-1 sponsored by the American […]
For the deadliest animals on earth, venom is their deadly weapon. They use venom to defend themselves or attack predators. There are hundreds of animals in nature with hypodermic syringes that […]
1 Blocking the function of special proteins may increase the effectiveness of immunotherapy Immunotherapy can attack cancer cells by stimulating the patient’s own immune system, which can quickly alleviate the diseases […]
Ono Pharmaceutical recently announced that its BTK inhibitor Velexbru (tirabrutinib hydrochloride, 80mg tablet) has been approved in Japan for the treatment of Fahrenheit macroglobulinemia (WM) and lymphocytic lymphoma (LPL). Velexbru is a highly […]
Long-term hypertension in Hypertension: may damage the vascular health of the brain. Doi:10.1161/HYPERTENSIONAHA.120.15073. Recently, in a study published in the international journal Hypertension, scientists from the University of Michigan School […]
In a recent study, scientists from the St. Jude Children’s Research Hospital discovered LC3-related endocytosis (LANDO) and its role in neuroinflammation. This discovery has deepened researchers’ understanding of potential Alzheimer’s disease treatment. The […]
In a recent study, researchers from Boston Children’s Hospital, Harvard Medical School and Washington University in St. Louis found that two drugs inhibited SARS-CoV-2, which causes COVID-19, in human cell […]
A recent clinical trial found that PARP inhibitors can be used to treat advanced male prostate cancer with BRCA1/BRCA2 gene mutations. The relevant results of the study have been published in […]